Literature DB >> 10068711

Neurologic complications of systemic cancer.

H B Newton1.   

Abstract

Neurologic complications occur frequently in patients with cancer. After routine chemotherapy, these complications are the most common reason for hospitalization of these patients. Brain metastases are the most prevalent complication, affecting 20 to 40 percent of cancer patients and typically presenting as headache, altered mental status or focal weakness. Other common metastatic complications are epidural spinal cord compression and leptomeningeal metastases. Cord compression can be a medical emergency, and the rapid institution of high-dose corticosteroid therapy, radiation therapy or surgical decompression is often necessary to preserve neurologic function. Leptomeningeal metastases should be suspected when a patient presents with neurologic dysfunction in more than one site. Metabolic encephalopathy is the common nonmetastatic cause of altered mental status in cancer patients. Cerebrovascular complications such as stroke or hemorrhage can occur in a variety of tumor-related conditions, including direct invasion, coagulation disorders, chemotherapy side effects and nonbacterial thrombotic endocarditis. Radiation therapy is the most commonly employed palliative measure for metastases. Chemotherapy or surgical removal of tumors is used in selected patients.

Entities:  

Mesh:

Year:  1999        PMID: 10068711

Source DB:  PubMed          Journal:  Am Fam Physician        ISSN: 0002-838X            Impact factor:   3.292


  9 in total

1.  Intra-arterial carboplatin and intravenous etoposide for the treatment of metastatic brain tumors.

Authors:  Herbert B Newton; Mary A Slivka; Carol Volpi; Eric C Bourekas; Gregory A Christoforidis; Melissa A Baujan; Wayne Slone; Donald W Chakeres
Journal:  J Neurooncol       Date:  2003-01       Impact factor: 4.130

2.  Brain metastases from fallopian tube carcinoma responsive to intra-arterial carboplatin and intravenous etoposide: a case report.

Authors:  H B Newton; C Stevens; M Santi
Journal:  J Neurooncol       Date:  2001-12       Impact factor: 4.130

3.  Clinical impact of cerebral infarction in patients with non-small cell lung cancer.

Authors:  Moriyasu Anai; Koichi Saruwatari; Tokunori Ikeda; Seitaro Oda; Yuka Tajima; Takayuki Jodai; Shinya Sakata; Shinji Iyama; Yusuke Tomita; Sho Saeki; Hidenori Ichiyasu; Takuro Sakagami
Journal:  Int J Clin Oncol       Date:  2022-02-22       Impact factor: 3.402

4.  Retrospective analysis of the efficacy and tolerability of levetiracetam in brain tumor patients.

Authors:  Herbert B Newton; Samuel A Goldlust; Dennis Pearl
Journal:  J Neurooncol       Date:  2006-03-16       Impact factor: 4.130

5.  Attributes of cancer patients admitted to the emergency department in one year.

Authors:  Muallaoglu Sadik; Karagün Ozlem; Mertsoylu Huseyin; Besen AliAyberk; Sezer Ahmet; Ozyilkan Ozgur
Journal:  World J Emerg Med       Date:  2014

6.  Atrial fibrillation in cancer patients who develop stroke.

Authors:  Alia Khamis; Ala Emad Shaban; Tamer Salhab Altamimi; Zakaria Walid Shkoukani; Ismail Hamam
Journal:  Cardiooncology       Date:  2022-05-18

7.  Safety and efficacy of intravenous thrombolysis in patients with acute stroke and active cancer: retrospective cohort study.

Authors:  Maria Giulia Mosconi; Andrea Capponi; Patrizia Pierini; Valeria Caso; Maurizio Paciaroni
Journal:  Neurol Sci       Date:  2022-03-24       Impact factor: 3.830

8.  Metastatic Melanoma With Leptomeningeal Disease.

Authors:  Amanda M Marinova; Jennifer L Reilly; Victoria Wong; Stephanie Weiss; Anthony J Olszanski
Journal:  J Adv Pract Oncol       Date:  2021-01-01

9.  West Nile Virus Encephalitis in a Patient with Neuroendocrine Carcinoma.

Authors:  Romina Deldar; Derek Thomas; Anna Maria Storniolo
Journal:  Case Rep Oncol Med       Date:  2016-07-19
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.